Bangladesh vs Egypt: Antiretroviral therapy coverage
Bangladesh
41.0%
in 2024
Egypt
45.0%
in 2024
Bangladesh rank
131st
Egypt rank
129th
Antiretroviral therapy coverage over time
- Bangladesh
- Egypt
How they compare
Egypt currently reports 45.0% against 41.0% in Bangladesh, a difference of 4.0%.
That makes Egypt's figure about 1.1 times Bangladesh's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Egypt ahead.
Bangladesh ranks 131st and Egypt ranks 129th of 143 countries.
Across the 3 decades both report, Bangladesh averaged higher in 2 and Egypt in 1.
Head to head by decade
| Decade | Bangladesh | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 0.6% | 0.5% | Bangladesh |
| 2010s | 14.1% | 9.9% | 4.2% | Bangladesh |
| 2020s | 34.2% | 34.4% | 0.2% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Bangladesh or Egypt?
- Egypt, at 45.0% against 41.0% in Bangladesh as of 2024.
- What is the difference in antiretroviral therapy coverage between Bangladesh and Egypt?
- 4.0%, with Egypt ahead.
- How many years of comparable data are there for Bangladesh and Egypt?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Egypt rank globally for antiretroviral therapy coverage?
- Bangladesh ranks 131st and Egypt ranks 129th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.